The funds will allow the company to accelerate the development of its chemotherapy drug candidate targeting solid tumors Poitiers, France, January 20, 2020 – Seekyo, a privately-owned biotech start-up specializing in the development of the next generation of chemotherapies,  … Read More »

Philadelphia, PA, (January 16, 2020)—ThinkGen, a leading global pharmaceutical market research and consultancy firm, announced it has partnered with PharmaVOICE to produce the magazine’s monthly Therapeutic Digest Series. The first eBook, on gene therapy, was issued mid-Janu … Read More »

The survey’s latest findings are taken from the opinions of sponsors and CROs globally PHILADELPHIA, PA – January 16, 2020: Signant Health, released the findings from its latest “State of eConsent” report today, highlighting the sentiments, successes, and challenges of eCons … Read More »

Pinterest is giving more people access to its mental health and wellbeing self-help exercises, with the tools now being made available in nine new regions. As per Pinterest: “Today we’re bringing our collection of emotional well-being activities to Pinners in nine additional … Read More »

SAN FRANCISCO, CA, Jan 15, 2020 – (ACN Newswire) – Novotech, the largest biotech CRO in Asia Pacific, says the region has had a record year by number of studies, experienced world-class sites and investigators, and patient enrollment. Novotech released its ‘Asia-Pacific Indu … Read More »

Former Celgene executive Heffron to oversee Zynteglo launch Treatment for rare, severe blood disorder costs $1.8 million Bluebird Bio Inc. named a new leader for its European operations as the biotech company rolls out a $1.8 million gene therapy for patients afflicted with … Read More »

London, UK – January 14th, 2020: Raremark, the leading patient-data platform in rare disease, is pleased to announce additions to its executive team to speed the company’s pursuit of more treatments for rare medical conditions. Industry experts Neil Rotherham, Tim Davis and … Read More »

The Food and Drug Administration has gotten faster at approving new prescription drugs over the past four decades, but the evidence it relies on in making those decisions is getting weaker, according to new research published Tuesday. As a result, there are more cures and tr … Read More »

Eli Lilly and Co. LLY, -0.23% said Tuesday it is planning to add two more cheaper versions of its insulin product Humalog starting in mid-April. The drug company said its Humalog Mix75/25 KwikPen and Humalog Junior KwikPen will have list prices that are 50% lower than brande … Read More »

Roche (SIX: RO, ROG; OTCQX: RHHBY) has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based testing in oncology. As the understanding of the genomic drivers of cancer evolves, NGS has … Read More »

Domain Therapeutics, a biopharmaceutical company specialized in the discovery and development of new drug candidates targeting G Protein-Coupled Receptors (GPCR) in neurology, oncology and rare diseases, announces it has closed a €6 million ($6.7M) debt financing to expand i … Read More »

AstraZeneca announced that after a recommendation from an independent Data Monitoring Committee, it was abandoning its Phase III STRENGTH trial for Epanova (omega-3 carboxylic acids) for mixed dyslipidemia (MDL). Epanova is a fish oil-derived combination of free fatty acids … Read More »

As more gene therapies are set to come down the pipeline, payers and employers can proactively prepare for those products in several different ways, according to a new white paper from CVS Health. In the report, the healthcare giant offers a four-point strategy health plans … Read More »

SAN DIEGO, California – The snapIoT platform is part of a groundbreaking pilot clinical study for adults with mild cognitive impairment. snapIoT, the fastest-growing “Platform as a Service” (PaaS) provider of mobile-connected self-service solutions for clinical trials, annou … Read More »

Galen, the privately owned global pharmaceutical sales and marketing company, and member of the Almac Group, today announced the completion of a multi-million dollar acquisition and takeover of boutique healthcare company, POA Pharma. The move enables Galen to significantly … Read More »

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients’ unmet needs and solve therapeutic problems, today reported that the U.S. Food and Drug Administration (FDA) i … Read More »

ThinkGen, a leading global pharmaceutical market research and consultancy firm, announced Bart Weiner to take over as the new President. The previous President, Noah Pines, will be overseeing the company as CEO. Upon joining the company, Bart said, “I am excited to be joinin … Read More »

• Acquisition of worldwide exclusive rights adds extensive anti-IL-11 platform to Boehringer Ingelheim pipeline portfolio • Boehringer Ingelheim aims to develop therapies for multiple fibrotic human disorders, including non-alcoholic steatohepatitis (NASH) and interstitial l … Read More »

Caroline O. Pardo, Ph.D., General Manager for Haymarket Medical Education (HME), is pleased to announce that HME, based in Paramus, NJ, has been accredited as a provider of interprofessional continuing education (IPCE) by the Accreditation Council for Continuing Medical Educ … Read More »

AUSTIN, TX, January 9, 2020 – Today, SubjectWell, the risk-free clinical trials marketplace, announced it has expanded its patient recruitment services into the United Kingdom, Ireland and South Africa. Supplementing its current footprint in the U.S. and Canada, the expansio … Read More »